BCL6 and B-cell non-Hodgkin lymphoma: Three specimens of 182 (1.6%) showed MYC and BCL6 rearrangements, which according to the ICC, is diagnostic of the provisional entity high-grade B-cell lymphoma with MYC and BCL6 rearrangements.